POPULARITY
5 episodes with DePuy
3 episodes with DePuy
3 episodes with DePuy
3 episodes with DePuy
3 episodes with DePuy
2 episodes with DePuy
2 episodes with DePuy
2 episodes with DePuy
2 episodes with DePuy
Send us a textJoin host Aaron Moncur as he sits down with Dr. Stuart Grant, a seasoned med tech innovator with over 25 years of experience at industry giants like Johnson & Johnson and DePuy. Dr. Grant shares his journey from design engineering to founding his own consultancy, offering invaluable insights into medical device development, regulatory challenges, and the future of medical technology.Main Topics:Career progression in medical device engineeringChallenges of starting a medical tech consultancyRegulatory differences across global marketsInnovation strategies in medical technologyAdvice for young engineersFuture trends in surgical robotics and AIAbout the guest: Dr. Stuart Grant is a seasoned expert in the MedTech industry with over 20 years of experience at major companies like Johnson & Johnson and DePuy Synthes. In 2023, he founded Archetype MedTech, a consultancy that helps medical device companies achieve market approval through innovation strategy, technical evaluations, and team training. He holds advanced innovation and project management degrees and is a Chartered Engineer with several medical device patents. In addition to his technical work, Stuart lectures on innovation history and is a visual artist. His international experience and multidisciplinary expertise make him a key advisor for MedTech startups and scale-ups.Links:Dr. Stuart Grant - LinkedIn Archetype MedTech Website The Idea Factory: Bell Labs and the Great Age of American InnovationExactly How Precision Engineers Created the Modern World
Traci DePuy talks about her journey in the event marketing space, from her start as a PR representative to the Chief Marketing Officer for one of the largest associations of event professionals.
On this Live Greatly podcast episode, Kristel Bauer sits down with Willie Pietersen, author of Leadership—The Inside Story: Time-Tested Prescriptions for Those Who Seek To Lead. Willie shares stories, experiences and the secret sauce of leadership learned from his time being CEO of multibillion-dollar businesses, a professor at Columbia University's Graduate School of Business, and a consultant to some of the world's biggest and best-known organizations. Tune in now! Key Takeaways From This Episode How leadership is all about people Some big lessons Willie learned amid his leadership journey How to get better at receving feedback and why it is important Stories about what makes a great leader About Willie Pietersen: Willie Pietersen was raised in South Africa, and received a Rhodes Scholarship to Oxford University. After practicing law, he embarked on an international business career. Over a period of twenty years he served as the CEO of multibillion-dollar businesses such as Lever Foods, Seagram USA, Tropicana and Sterling Winthrop's Consumer Health Group. In 1998, Willie was named Professor of the Practice of Management at the Columbia University Graduate School of Business. He specializes in strategy and the leadership of change, and his methods and ideas, especially Strategic Learning, are widely applied within Columbia's executive education programs, and also in numerous corporations. He has served as a teacher and advisor to many global companies, including Aviva, Bausch & Lomb, Boeing, Chubb Corp., Deloitte, DePuy, Electrolux, Ericsson, ExxonMobil, Henry Schein, Inc., Federal Home Loan Bank of Atlanta, Novartis, Salt River Project, SAP, UGI, United Nations Federal Credit Union and also the Girl Scouts of the USA. Willie is the author of three books and numerous articles. His latest book is Leadership—The Inside Story: Time-Tested Prescriptions for Those Who Seek to Lead. Connect with Willie: Website: https://williepietersen.com/ LinkedIn: https://www.linkedin.com/in/willie-pietersen-286b149/ Get Willie's Book: https://williepietersen.com/books/leadership-the-inside-story-time-tested-prescriptions-for-those-who-seek-to-lead/ About the Host of the Live Greatly podcast, Kristel Bauer: Kristel Bauer is a corporate wellness expert, popular keynote and TEDx speaker, and the host of top-rated self-improvement podcast “Live Greatly”. Kristel is an Integrative Medicine Fellow & Physician Assistant with clinical experience in Integrative Psychiatry, giving her a unique perspective into optimizing mental well-being and attaining a mindset for more happiness and success in the workplace and beyond. Kristel decided to leave clinical practice in 2019 when she founded her wellness platform “Live Greatly” to share her message around well-being and success on a larger scale. With a mission to support companies and individuals on their journeys for more happiness, success, and well-being, Kristel taps into her unique background in healthcare, business, and media, to provide invaluable insights into high power habits, leadership development, mental well-being, peak performance, resilience, sales, success, wellness at work, and a modern approach to work/life balance. Kristel is the author of Work-Life Tango: Finding Happiness, Harmony and Peak Performance Wherever You Work (John Murray Business November 19, 2024). Kristel is a contributing writer for Entrepreneur and she is an influencer in the business and wellness space having been recognized as a Top 10 Social Media Influencer of 2021 in Forbes. A popular speaker on a variety of topics, Kristel has presented to groups at APMP, Bank of America, Commercial Metals Company, General Mills, Northwestern University, Mazda, Santander Bank and many more. She has been featured in Forbes, Forest & Bluff Magazine, Authority Magazine & Podcast Magazine, has contributed to CEOWORLD Magazine & Real Leaders Magazine, and has appeared on ABC 7 Chicago, WGN Daytime Chicago, Fox 4's WDAF-TV's Great Day KC and Ticker News. Kristel lives in the Chicago area with her husband and their 2 children. She can be booked for speaking engagements worldwide. To Book Kristel as a speaker for your next event, click here. Website: www.livegreatly.co Follow Kristel Bauer on: Instagram: @livegreatly_co LinkedIn: Kristel Bauer Twitter: @livegreatly_co Facebook: @livegreatly.co Youtube: Live Greatly, Kristel Bauer To Watch Kristel Bauer's TEDx talk of Redefining Work/Life Balance in a COVID-19 World click here. Click HERE to check out Kristel's corporate wellness and leadership blog Click HERE to check out Kristel's Travel and Wellness Blog Disclaimer: The contents of this podcast are intended for informational and educational purposes only. Always seek the guidance of your physician for any recommendations specific to you or for any questions regarding your specific health, your sleep patterns changes to diet and exercise, or any medical conditions. Always consult your physician before starting any supplements or new lifestyle programs. All information, views and statements shared on the Live Greatly podcast are purely the opinions of the authors, and are not medical advice or treatment recommendations. They have not been evaluated by the food and drug administration. Opinions of guests are their own and Kristel Bauer & this podcast does not endorse or accept responsibility for statements made by guests. Neither Kristel Bauer nor this podcast takes responsibility for possible health consequences of a person or persons following the information in this educational content. Always consult your physician for recommendations specific to you.
Join us for an inspiring conversation with entrepreneur Chris DePuy as he takes us through his seemingly unlikely journey from truck driver to the mastermind behind MaxAiir Inflatapark. Chris shares the process of designing a custom inflatable park with features like obstacle courses and plunge pits, all aimed at creating unforgettable experiences for both private events and public gatherings.Chris' story doesn't stop there. You'll hear about how his inflatable rental business started as a community fundraiser, then kept growing. Despite facing daunting challenges like a shoulder injury and the impact of COVID-19, Chris pivoted to rental properties, showcasing his resilience and adaptive thinking. This episode highlights the dual success of his ventures and the joy of contributing to community celebrations, proving that challenges can be the stepping stones to greater achievements.Discover the personal side of Chris' entrepreneurial journey as he reflects on selling honey buns at a prior job, finding a mentor, and how family involvement has been vital to his success. We explore innovative strategies for fundraising through value-based trading and the collaborative spirit that fuels the business community in downtown Marion. Chris' story is a powerful testament to the importance of a supportive network and the transformative power of community collaboration.Guest Links:Website: bookmaxaiir.comFacebook: facebook.com/bookmaxaiirMain Street Reimagined:Facebook: facebook.com/MainStreetReimaginedThe Main Street Reimagined Podcast, Watch on YouTube: https://www.youtube.com/playlist?list=PLqfkmF5bRH0od1d3iiYKs3oEn_gvMYk7NHenry Development Group:Facebook: facebook.com/henrydevelopmentgroupWebsite: www.henrydevelopmentgroup.comDeveloping News Newsletter: https://mailchi.mp/33110524eb5c/developing-newsLuke Henry:LinkedIn: linkedin.com/luhenryFacebook: facebook.com/luke.henry.148#EntrepreneurJourney#SmallBusinessSuccess#CommunityImpact#InflatablePark#ResilienceInBusiness#CreativeEntrepreneurship#BusinessPivot#MarionOhio#SupportLocal#AdaptiveThinking#InspiringStories#BusinessCommunity#FamilyBusiness#StartupSuccess#FundraisingIdeas
Anya first stumbled across the opportunity to learn the craft of metal smithing while traveling solo in India for 6 months in 2016. Little did she know that her love for the craft would deepen and grow over the years to turn into her own small business of WabiSabi Silver. Anya is committed to living a joyful life that centers around sustainability. She is currently a part of a team that is at the beginning stage of building a natural building/permaculture educational site where her yurt and newly built straw bale art studio live. Her efforts towards sustainability show up in her creations through the stones she chooses and through recycling and reclaiming metals. It also shows up in her creative process, taking time to recharge and spark inspiration through the purposeful work of building community and reciprocal relationship with the land. Anya has always loved crafting and building things with her hands and particularly enjoys the meditative quality required of the process. Her hope is to offer pieces infused with a deep care and sweetness that can be felt by the wearer. To find out more about the sustainable building and permaculture education project Anya spoke of please visit earthvilleinstitute.org You can follow Anya and see her beautiful work at the links below. Instagram: @wabisabi_silver Website: wabisabisilver.com If this podcast means something to you and you would like to support it, please take a a moment to give it a few kinds word with a written review on your favorite podcast listening platform. This helps me share the podcast with others. You can also share a favorite episode or consider joining our Slowmade Podcast Patreon community. You support literally makes this podcast possible. Thank you so much! You can follow along or reach out to Christine on Instagram: @christinemighion or @slowmadepodcast or you can send her an email at: info@christinemighion.com
We got Davey and the TrillDawg in to help see off Nashville SC's 2023. Topics hit include:Another first round playoff exitFan sentimentThis janky playoff formatSam Surridge's 2024 prospectsHow will Nashville SC's 2023 be remembered?Moment of the seasonGoal of the seasonAnnual Non-Hany Mukhtar MVP AwardFarewells to Dax, Fafa, HaakensonEarly signings of Dru Yearwood, McKinzie GainesWhat are the other off-season priorities?Reaction to the US Open Cup newsLooking forward to Concacaf Champions CupWhat would it mean if Nashville made a coaching or front office change?Up the 'Yotes forever. COYBIG. We'll see ya in '24.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here's what you need to know for today, November 1, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. GE HealthCare posted third-quarter earnings this week. Fast Five hosts Sean Whooley and Danielle Kirsh go over some of the financial details for the quarter and how individual segments performed. Stereotaxis announced the first surgical robot procedure with Abbott's cardiac mapping technology. Hear what procedures it was used in and what doctors thought about the success of the procedures. The first U.S. procedures using ZimeVie's 4.5mm Mobi-C device were also announced this week. Whooley details what surgeons thought about using the implant in these procedures. Abbott is teaming up with NFL player Damar Hamlin for its 'Heartmates Program.' The Fast Five hosts discuss Hamlin's optimism as an ambassador for the company and what the goal of the Heartmates Program is. J&J DePuy is laying off workers in Colorado. Find out what jobs will be affected by this latest round of layoffs and the reason behind the cuts.
Michael Charles “Mike” Walters, departed this life on Saturday, October 7, 2023. He was preceded in death by his father, Andy Walters. He is survived by his wife, Caroline of 26 years; his sons, Peyton and Ian; his mother, Peggy Walters; his sister, Denise Burchett (Fred); his brother, John Walters (Sally); nieces, Christine and Brittany; nephews, Dean and Ryan; and numerous relatives in Texas. Mike was born and raised in Richmond, Va. He graduated from Trinity Episcopal HS and received a BS in Economics from The University of Virginia. He enjoyed a 34-year career in medical device sales with DePuy...Article LinkSupport the show
Stu and I talk about the changes happening in orthopedics. Stu walks young sales reps in how best to start out. Then for those experienced sales reps in a big organizations who are frustrated, Stu offers a way out, a way to achieve control and agency in their sales career - the Broker Rep. The Q&A flow. Stu, before we dive in... tell us about your journey. How did you move from working in sales for DePuy to becoming a Change Agent in sales? How has this diverse experience across different positions and companies shaped your approach to driving change and innovation in the industry? You have been in orthopedics sales for 30 years... what has changed? What are the most dramatic changes in the last 5 and 10 years? Where is the true power in the market for the big 5 Orthos? How has the earning potential of 1099 and W2 reps changed over time? How are non-competes deployed with new salespeople and what are the implications of signing non-competes? What are some ways salespeople get marginalized today with product line changes, commission changes, territory changes, etc? What is a Device Broker and why should some salespeople consider being a Broker? What are the limits of an Agent Broker in orthopedics? What are the advantages for Orthopedic surgeons and facilities to work with a broker? Who is your ideal customer? Who is not a good fit to work with you or a Broker? Could you tell me how listeners can find out more about you and ASCdx ? --- Support this podcast: https://podcasters.spotify.com/pod/show/tigerbuford/support
Microbot Medical's completion of a pre-clinical study for its endovascular surgical robot signifies a significant milestone for the company. Fast Five hosts Danielle Kirsh and Sean Whooley explain what the surgical robot does and what the outcome of the pre-clinical study was. The FDA clearance of Boston Scientific's Embold Soft & Packing coils demonstrates the company's commitment to expanding its portfolio of innovative solutions for embolization procedures. Hear about what the coils are designed for and how it streamlines hospital workflows on today's episode. Integra Lifesciences' completion of enrollment in the DuraSorb monofilament mesh IDE study is a significant step toward gathering valuable clinical data for this product. Whooley details what the study will evaluate and how optimistic are executives at the company. Federal prosecutors claim a former DePuy Synthes sales representative defrauded an undisclosed Boston area hospital, with hundreds of thousands of dollars worth of spine products involved. Kirsh and Whooley share what the sales representative is accused of, how it allegedly benefitted the sales rep and DePuy Synthes' response. The resignation of NeuroPace's CEO and the appointment of a former Integer executive as his successor mark a significant leadership change within the company. Whooley and Kirsh discuss the details behind the resignation and who is taking over the corner office. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
The availability of Insulet's Omnipod 5 automated insulin delivery system in the UK is a significant development in diabetes management. Fast Five hosts Sean Whooley and Danielle Kirsh explain the system's impact on people with diabetes in the regions where it is already available and where the company plans to launch next. Teleflex's partnership with Insighters Medical to distribute Insighters' video laryngoscope is an exciting development in airway management. Whooley provides the details of the partnership and what Insighters technology does for patients and providers. A new partnership between GE Healthcare and DePuy Synthes allows GE HealthCare's imaging technologies and DePuy Synthes' orthopedic solutions, aiming to optimize surgical planning and improve the accuracy of spinal procedures. The Fast Five hosts discuss the technology being shared and how this partnership complements GE Healthcare's ongoing partnerships. The partnership between Philips and Biotronik signifies a joint effort to enhance care delivery in out-of-hospital cardiology labs. This collaboration aims to combine Philips' expertise in remote monitoring and digital health solutions with Biotronik's innovative cardiovascular technologies. Hear how the combination of technologies will affect patients. Surgalign's decision to file Chapter 11 bankruptcy to sell its global hardware and biologics business is a strategic move aimed at restructuring and focusing on core operations. The Fast Five hosts talk about what the asset purchase agreement states and if the company plans to continue operating as usual. Check out the show notes at MassDevice.com/podcast.
This week we're replaying a classic episode where your hosts Steve Lowry and Yvonne Godfrey interview Michael A. Kelly of Walkup, Melodia, Kelly & Schoenberger (https://www.walkuplawoffice.com) Remember to rate and review GTP in iTunes: Click Here To Rate and Review Episode Details: Accomplished California personal injury lawyer Michael A. Kelly, a shareholder at Walkup, Melodia, Kelly & Schoenberger and recent Trial Lawyer Hall of Fame inductee, shares how he secured justice for the first of thousands of victims of a defectively designed medical device. On December 5, 2007, U.S. Air Force veteran Loren "Bill" Kransky underwent hip surgery in Montana, receiving a DePuy ASR Acetabular Hip System orthopedic implant. DePuy, a subsidiary of Johnson & Johnson, first put the ASR Acetabular Hip System on the market in Europe in 2004, and soon after began receiving notifications from prominent surgeons that the device was flawed. Despite receiving these notifications, DePuy continued to market the metal implant as a low-wear product that required only one surgery and failed to report product issues to American doctors. On August 4, 2010, a recall was issued and the Depuy ASR Acetabular Hip System was labeled as defective, but the damage was already done for millions of patients, including Loren. Following the recall, Loren underwent revision surgery to have the implant removed because it was shedding metal debris into the tissue of his hip and bloodstream. In March 2013, a Los Angeles jury returned a verdict in favor of Loren, awarding $8,338,136.12 in damages for the pain caused by the defective design and ultimately helping to facilitate a $2.5 billion national settlement for all victims. Click Here to Read/Download Trial Documents Guest Bio: Michael A. Kelly Mike Kelly is one of the nation's top personal injury attorneys. For four decades he has protected consumers from corporate greed, medical mistakes, dangerous household products, unsafe medical devices, and motor vehicle accidents of every kind. He has tried, settled, and arbitrated more than 200 cases where the recovery by his client exceeded $1 million. In 2020 he helped negotiate the multibillion-dollar resolution of the 2017 California wildfire lawsuits brought against utility giant PG&E. Before that, his $8.341 million verdict in the first DePuy ASR/Johnson & Johnson metal-on-metal artificial hip litigation helped produce a $2.5 billion national settlement for all victims. In 2021 Mike was the number one vote-getter for the second year in a row on the 2021 list of Northern California “Super Lawyers”. A member of the prestigious Inner Circle of Advocates, Kelly was also included on the “Top 10” and “Top 100” list of lawyers in Northern California for the 18th time, as well as being selected by Best Lawyers to its prestigious roster for the 20th consecutive year. Recognized for his leadership in some of the most significant consumer protection cases in our state, Kelly made the list of the Los Angeles Daily Journal's 2021 Top Plaintiff Lawyers and was inducted into Lawdragon's Hall of Fame for his many years of pro-consumer successes, most recently demonstrated by his role in the litigation against the giant utility PG&E for the damage caused by the 2017-2018 Northern California wildfires and the devastating Butte County Camp Fire. When resolution by mediation or settlement fails, Kelly is ready to take his clients' cases before juries. Recent trials have produced a $4 million jury verdict against the Golden Gate Bridge Highway and Transportation District for the death of a pedestrian struck by one of its buses, a $5.6 million jury verdict against a Super Shuttle driver for the death of a retired restaurateur, a $12.75 million recovery against a domestic automaker(auto rollover), a $10.5 million settlement for the wrongful death of a single mother, and a major 8-figure confidential settlement against Kaiser Health Plan for a catastrophically injured infant. His $8.35 million verdict on behalf of a construction worker who lost an arm showed his skill in work-site injury cases. His $23.2 million jury verdict in a birth injury medical malpractice case in Minnesota ranks among that state's largest verdicts for obstetrical injury. Beyond stellar results for his clients, Kelly is proud of his many contributions to the legal community. He is a speaker for 360 Advocacy for whom he chairs its annual Trucking Litigation program. He teaches regularly for NITA, The Rutter Group, ABOTA, the Consumer Attorneys of California, AAJ, SFTLA, and the Bar Association of San Francisco. He served for 10 years as the Director of Teacher Training programs for the National Institute of Trial Advocacy and remains a member of its Board of Governors. He has long been active in protecting the rights of the underrepresented, working for pedestrian and bicyclist safety, lobbying for compensation fairness for medical malpractice victims, and protecting the rights of the LGBT community. Read Full Bio Show Sponsors: Legal Technology Services - LegalTechService.com Digital Law Marketing - DigitalLawMarketing.com Harris Lowry Manton LLP - hlmlawfirm.com Free Resources: Stages Of A Jury Trial - Part 1 Stages Of A Jury Trial - Part 2
This week on Where Legends Are Made...we sit down with Adam Depuy and talk about his transition from Street Stocks to 305 Sprint Cars. We also check in with Stirling Lubricants Sportsman rookie Behr Grover as he sets out for the 2023 campaign.
Tune in for today's industry updates.
Tune in for today's industry updates.
- 2022 COG T-SHIRTS! BUY NOW! http://www.cornerofthegalaxy.com/SHOP - SUBSCRIBE TO OUR PODCAST: http://cornerofthegalaxy.com/subscribe/ - COG LA GALAXY DISCORD: https://discord.gg/drr9HFZY2P COG STUDIOS, Calif. -- It was almost too quiet! Then Thursday erupted with a series of deals that have set the LA Galaxy into the preseason. On today's show, hosts Josh Guesman and Eric Vieira discuss the Galaxy's moves as they amassed some General Allocation Money and moved some pieces around. So what can we make of it all? The guys will start by discussing Sacha Kljestan's retirement and their peek at the new authentic second kit. There are almost too many words to describe what Kljestan has meant to the MLS and the Galaxy. So will there be a vacuum that needs to be filled? Josh and Eric will then dive into the acquisitions of center-back Chris Mavinga and midfielder Memo Rodriguez. Which of those should you be most excited about? And what questions does Mavinga answer in the backline? Finally, the guys will discuss Nick DePuy's departure from LA and why Nashville fleeced Greg Vanney while flipping another Galaxy player. We've got a great show for you tonight, and we can't wait to start the season. Are the Galaxy ready? Who will be the next Designated Player? A lot of questions with players reporting this weekend.
This week Steve and Yvonne interview Jake Zimmerman of The Zimmerman Firm (http://zimmerman-firm.com/) and Genevieve Zimmerman of MeshBesher and Spence (https://www.meshbesher.com/). Remember to rate and review GTP in iTunes: Click Here to Rate and Review View/Download Trial Documents Guest Bios: Jake Zimmerman Jake Zimmerman has litigated on behalf of plaintiffs whose total recoveries approach a billion dollars. Much of his practice focuses on intellectual property disputes, and on patent litigation and licensing in particular. He has also litigated high-stakes cases on behalf of personal injury plaintiffs and defendants. He was selected as a 2019 Attorney of the Year in Minnesota for his groundbreaking work on behalf of a parent whose son was killed at Sandy Hook. He was again selected as an Attorney of the Year in Minnesota in 2021 for his role in appeals from the Bair Hugger MDL litigation against 3M. Jake graduated Magna Cum Laude from the University of Minnesota School of Law. He lives in Saint Paul, Minnesota with his wife, Genevieve, and two wonderful children. Read Full Bio Genevieve Zimmerman Genevieve presently serves as court-appointed Co-Lead Counsel for plaintiffs in MDL 2666: In re Bair Hugger Products Liability Litigation. Genevieve was trial counsel in the only bellwether trial. The Bair Hugger MDL includes claims brought by patients who allege the Bair Hugger patient warming system caused deep joint infections following total hip and total knee replacement surgeries. Genevieve is also Co-Lead Counsel for Plaintiffs in MDL 2775: In re Smith & Nephew Birmingham Hip Resurfacing Products Liability pending in the District of Maryland. The MDL includes claims brought on behalf of patients who required revision surgery as a result of defective BHR products. Plaintiffs have successfully defeated a motion to dismiss based on preemption and tried the first MDL bellwether case in July 2021. After a three-week trial, the jury agreed Smith & Nephew was negligent for its false or misleading communications to orthopedic surgeons. Since 2013, Genevieve has served as a court-appointed member of the Plaintiffs' Lead Counsel Committee for MDL 2441: In re Stryker Rejuvenate and ABGII Hip Implant Products Liability Litigation, and is also one of four attorneys appointed to the Settlement Committee for the Stryker MDL, which helped to negotiate a settlement in excess of $1.43 billion. Additionally, in May of 2019, Genevieve was appointed to the Plaintiff's Executive Committee of the 3M Combat earplug litigation MDL. She is one of 14 lawyers appointed by Judge Englehardt to MDL 2740, In re Taxotere, which includes claims brought by women who have suffered permanent baldness as a result of the use of Taxotere. She was court appointed to the PSC for the Biomet MDL in the Northern District of Louisiana, and helps patients suffering from hips made by Smith & Nephew, DePuy, Wright/MicroPort, and Zimmer. Genevieve's past work includes helping heart defibrillator patients after a Guidant recall in 2006. She represented patients who suffered serious injuries and death following the use of the recalled prescription drug Vioxx. She has assisted hundreds of clients in obtaining settlements for defective products including Yaz, transvaginal mesh, hernia mesh, Actos, to name a few. During 2007-2009, Genevieve spent nearly 75% of her time providing pro bono legal services to the survivors and families who lost loved ones as a result of the I-35W Bridge Collapse. The consortium was successful in obtaining recoveries exceeding $75 million. Genevieve serves the community through ongoing pro bono work where she has represented victims of domestic violence seeking to obtain court orders for protection, immigrants seeking to update immigration documents, and high school students seeking protection of their first amendment rights to equal access to school facilities. Genevieve is currently the immediate Past President of the Minnesota Association for Justice, having served on the Board of Governors since 2009, and was proud to receive the “Member of the Year” award in 2012, and the “Star” award in 2021. She is a past member of the Board of Governors for the American Association for Justice. Genevieve has been rated by SuperLawyers as a Super Lawyer since 2014. On a personal note, Genevieve volunteers and raises money for scholarship funds for her alma mater, St. Paul Central High School. In whatever free time she has left, she enjoys travel, skiing, recreational marathons, teaching her kids how to swing a hammer, shovel class five, and cheering for her Minnesota sports teams. Read Full Bio Show Sponsors: Legal Technology Services - LegalTechService.com Digital Law Marketing - DigitalLawMarketing.com Harris Lowry Manton LLP - hlmlawfirm.com Free Resources: Stages Of A Jury Trial - Part 1 Stages Of A Jury Trial - Part 2
In this episode David Uba, Chief Executive Officer at Excelsior Orthopaedics and Buffalo Surgery Center, discusses his experience managing an ASC. Join us as he delves into management, maximizing value and optimizing your outcomes, and the importance of data collection in the ASC space.David Uba is the CEO of an orthopaedic system and ASC and is a paid consultant of an affiliate of DePuy Synthes. All views and opinions expressed by David Uba are based on his own knowledge and experience.This episode is sponsored by DePuy Synthes, the Orthopedic Company of Johnson and Johnson.
In this episode David Uba, Chief Executive Officer at Excelsior Orthopaedics and Buffalo Surgery Center, discusses his experience managing an ASC. Join us as he delves into management, maximizing value and optimizing your outcomes, and the importance of data collection in the ASC space.David Uba is the CEO of an orthopaedic system and ASC and is a paid consultant of an affiliate of DePuy Synthes. All views and opinions expressed by David Uba are based on his own knowledge and experience.This episode is sponsored by DePuy Synthes, the Orthopedic Company of Johnson and Johnson.
Riz Hatton shares the latest industry news.
Oral Arguments for the Court of Appeals for the First Circuit
US, ex rel. Nargol & Langton v. DePuy Orthopaedics, Inc.
Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.11.15.516661v1?rss=1 Authors: Kelberman, M., Rorabaugh, J. M., Anderson, C. R., Marriott, A., DePuy, S. D., Rasmussen, K., McCann, K. E., Weiss, J. M., Weinshenker, D. Abstract: Accumulation of hyperphosphorylated tau in the locus coeruleus (LC) is a ubiquitous feature of prodromal Alzheimers disease (AD), and LC neurons degenerate as AD progresses. Tau-mediated LC dysfunction may contribute to early neuropsychiatric symptoms, while loss of LC integrity is associated with conversion to cognitive impairment. Hyperphosphorylated tau alters firing rates in other brain regions, but its effects on LC neurons have not been described. The purpose of this study was to characterize changes in firing properties of LC neurons when they are the only cells containing hyperphosphorylated tau, as well as later in disease when {beta}-amyloid (A{beta}) and tau pathology is abundant in the forebrain. Single unit LC activity was recorded from anesthetized wild-type (WT) and TgF344-AD rats, which carry the APP/PS1 transgene. Similar to human AD, these rats develop hyperphosphorylated tau in the LC (at 6 months) prior to A{beta} or tau pathology in forebrain regions (at 12-15 months). At baseline, LC neurons from TgF344-AD rats were hypoactive at both ages compared to WT littermates, but showed elevated spontaneous bursting properties, particularly in younger animals. Differences in footshock-evoked LC firing depended on age, with 6-month TgF344-AD rats demonstrating aspects of hyperactivity, and aged transgenic rats showing hypoactivity relative to WT. Tau-induced alterations in LC firing rates may contribute to the pathophysiology of AD, with early hyperactivity associated with prodromal symptoms, followed by hypoactivity contributing to cognitive impairment. These results support further investigation into disease stage-dependent noradrenergic interventions for AD. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC
Keith Palmer is the Worldwide Vice President for Hip Reconstruction at DePuy Synthes, which is the orthopedic company of Johnson & Johnson. DePuy Synthes is focused on adapting their technology, techniques, and implants to provide stability, flexibility, and durability to an ever more active patient population. Keith reports, "When we think about our surgeons and our patients and keep them in mind, we have solutions that address unmet needs in patients that lead to improved outcomes. So, through our anterior advantage, our portfolio solutions, in particular, patients benefit from shorter hospital stays, quicker recovery times, and reduced use of pain medication when they're surgeon implants or comprehensive systems for hip replacement surgeries." "Our patients today are highly educated on different surgical technique offerings. They even think about what's best in terms of meeting their needs, the quicker recovery, and even going to outpatient surgery centers and ensuring that the time is reduced to help them get back to their active lifestyle quicker. But they're continuously involved in goal planning with the surgeon to be able to address some of these needs." @DePuySynthes #HipReplacement #HipReplacementSurgery jnjmedtech.com Download the transcript here
Keith Palmer is the Worldwide Vice President for Hip Reconstruction at DePuy Synthes, which is the orthopedic company of Johnson & Johnson. DePuy Synthes is focused on adapting their technology, techniques, and implants to provide stability, flexibility, and durability to an ever more active patient population. Keith reports, "When we think about our surgeons and our patients and keep them in mind, we have solutions that address unmet needs in patients that lead to improved outcomes. So, through our anterior advantage, our portfolio solutions, in particular, patients benefit from shorter hospital stays, quicker recovery times, and reduced use of pain medication when they're surgeon implants or comprehensive systems for hip replacement surgeries." "Our patients today are highly educated on different surgical technique offerings. They even think about what's best in terms of meeting their needs, the quicker recovery, and even going to outpatient surgery centers and ensuring that the time is reduced to help them get back to their active lifestyle quicker. But they're continuously involved in goal planning with the surgeon to be able to address some of these needs." @DePuySynthes #HipReplacement #HipReplacementSurgery jnjmedtech.com Listen to the podcast here
Riz Hattton shares the latest news on the Spine and Orthopedic industry.
Laura Dyrda shares the latest news on the Spine industry.
Total Knee Tips & Pearls From Dr. Adam Rosen (A Virtual Total Knee Fellowship Podcast)
This is the 100th Episode of the Total Knee Tips & Pearls PodcastSome techy stuff on TKARecommended Distal Femoral Resections8mm - Stryker Triathlon9mm - DePuy Attune9.5mm - Smith & Nephew10mm - Zimmer Persona, DJO, MicroportAnterior Flange Angle to Prevent Notching3 degrees - S&N, Zimmer5 degrees - DJO, DePuy6 degrees - Microport7 degrees - StrykerRecommended Tibial Slope0 degrees - Stryker PS, Aesculap3 degrees - Stryker CR, Aesculap, Persona PS, Attune PS, Microport, S&N5 degrees - Attune CR7 degrees - Attune CR, Persona CR1 mm Poly OptionsStryker, Zimmer, Depuy, S&NMetal Sensitive OptionS&N OxiniumZimmer Ti-NidiumMicroport NitrXDJO ArmourCoatAesculap Advanced Surface TechnologyTJO AurumNarrow OptionsZimmer, DePuy, S&N, AesculapSmallest - Zimmer 1 Narrow (55.5 mm M/L, 48.1 mm AP)Biggest - Aesculap F8 (82 MM M/L, 80.5 mm AP)Lots of stuff! Check with your reps and always refer to the technique manual, this is just a brief review but does not take the place of training and education. Support the show
Nick is a homesteader and soon-to-be retired Air Force E-6 that raises rabbits for food and showing. He got started about 10 years ago and has made tons of mistakes in housing, breeding and butchering and wants to share his … Continue reading →
This week your hosts Steve Lowry and Yvonne Godfrey interview Michael A. Kelly of Walkup, Melodia, Kelly & Schoenberger (https://dicellolevitt.com/) Remember to rate and review GTP in iTunes: Click Here To Rate and Review Episode Details: Accomplished California personal injury lawyer Michael A. Kelly, a shareholder at Walkup, Melodia, Kelly & Schoenberger and recent Trial Lawyer Hall of Fame inductee, shares how he secured justice for the first of thousands of victims of a defectively designed medical device. On December 5, 2007, U.S. Air Force veteran Loren "Bill" Kransky underwent hip surgery in Montana, receiving a DePuy ASR Acetabular Hip System orthopaedic implant. DePuy, a subsidiary of Johnson & Johnson, first put the ASR Acetabular Hip System on the market in Europe in 2004, and soon after began receiving notifications from prominent surgeons that the device was flawed. Despite receiving these notifications, DePuy continued to market the metal implant as a low-wear product that required only one surgery and failed to report product issues to American doctors. On August 4, 2010, a recall was issued and the Depuy ASR Acetabular Hip System was labeled as defective, but the damage was already done for millions of patients, including Loren. Following the recall, Loren underwent revision surgery to have the implant removed because it was shedding metal debris into the tissue of his hip and bloodstream. In March 2013, a Los Angeles jury returned a verdict in favor of Loren, awarding $8,338,136.12 in damages for the pain caused by the defective design and ultimately helping to facilitate a $2.5 billion national settlement for all victims. Click Here to Read/Download Trial Documents Guest Bio: Michael A. Kelly Mike Kelly is one of the nation's top personal injury attorneys. For four decades he has protected consumers from corporate greed, medical mistakes, dangerous household products, unsafe medical devices, and motor vehicle accidents of every kind. He has tried, settled, and arbitrated more than 200 cases where the recovery by his client exceeded $1 million. In 2020 he helped negotiate the multibillion-dollar resolution of the 2017 California wildfire lawsuits brought against utility giant PG&E. Before that, his $8.341 million verdict in the first DePuy ASR/Johnson & Johnson metal-on-metal artificial hip litigation helped produce a $2.5 billion national settlement for all victims. In 2021 Mike was the number one vote-getter for the second year in a row on the 2021 list of Northern California “Super Lawyers”. A member of the prestigious Inner Circle of Advocates, Kelly was also included on the “Top 10” and “Top 100” list of lawyers in Northern California for the 18th time, as well as being selected by Best Lawyers to its prestigious roster for the 20th consecutive year. Recognized for his leadership in some of the most significant consumer protection cases in our state, Kelly made the list of the Los Angeles Daily Journal's 2021 Top Plaintiff Lawyers and was inducted into Lawdragon's Hall of Fame for his many years of pro-consumer successes, most recently demonstrated by his role in the litigation against the giant utility PG&E for the damage caused by the 2017-2018 Northern California wildfires and the devastating Butte County Camp Fire. When resolution by mediation or settlement fails, Kelly is ready to take his clients' cases before juries. Recent trials have produced a $4 million jury verdict against the Golden Gate Bridge Highway and Transportation District for the death of a pedestrian struck by one of its buses, a $5.6 million jury verdict against a Super Shuttle driver for the death of a retired restaurateur, a $12.75 million recovery against a domestic automaker(auto rollover), a $10.5 million settlement for the wrongful death of a single mother, and a major 8-figure confidential settlement against Kaiser Health Plan for a catastrophically injured infant. His $8.35 million verdict on behalf of a construction worker who lost an arm showed his skill in work-site injury cases. His $23.2 million jury verdict in a birth injury medical malpractice case in Minnesota ranks among that state's largest verdicts for obstetrical injury. Beyond stellar results for his clients, Kelly is proud of his many contributions to the legal community. He is a speaker for 360 Advocacy for whom he chairs its annual Trucking Litigation program. He teaches regularly for NITA, The Rutter Group, ABOTA, the Consumer Attorneys of California, AAJ, SFTLA, and the Bar Association of San Francisco. He served for 10 years as the Director of Teacher Training programs for the National Institute of Trial Advocacy and remains a member of its Board of Governors. He has long been active in protecting the rights of the underrepresented, working for pedestrian and bicyclist safety, lobbying for compensation fairness for medical malpractice victims, and protecting the rights of the LGBT community. Read Full Bio Show Sponsors: Legal Technology Services - LegalTechService.com Digital Law Marketing - DigitalLawMarketing.com Harris Lowry Manton LLP - hlmlawfirm.com Free Resources: Stages Of A Jury Trial - Part 1 Stages Of A Jury Trial - Part 2
Molly Phannenstiel and Nathan DePuy are vanlifers who live in a sweet converted school bus and work for Outdoorsy. On this fun episode, Travis talks about his recent Salida Pole, Pedal, Paddle adventure with kids before getting into #vanlife fun with Mace, Nathan, and Molly.In This Episode: Check out our new title sponsor, The Feed Instagram | WebsiteBlue The Bus on InstagramNathan DePuy on InstagramMolly Phannenstiel on InstagramOutdoorsy on InstagramTravis Macy Instagram | WebsiteMark Macy on InstagramPast Episodes:Episode 40 - Josiah MiddaughEpisode 43 - Dr. Kevin Sprouse
Total Knee Tips & Pearls From Dr. Adam Rosen (A Virtual Total Knee Fellowship Podcast)
Do not take my word for it but do your research and verify everything. Here I'll review the four common cups many of us useZimmer G7 - ream under by 1 mm, 36 mm ID options at 50 with 10 degree and +5 lat offsetStryker Trident II Tritanium - ream line to line, 36 neutral option at 48 and 36 mm options with lip and offset at 52 mmDePuy Pinnacle - under by 1 mm, 2mm or line to line, 36 mm ID options at 52 mmSmith and Nephew - under by 1 mm or line to line, 36 mm ID option at 52 mmIf you are a 40 mm fan, you can get 40 mm with Zimmer at 54 mm, Stryker at 52 mm, Depuy and Smith and Nephew at 56 mm Support the show (https://www.patreon/TotalKneeTips)
This episode's Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: https://www.catalysthealthtech.com/ (CLICK HERE) — With over 25 years of leading technology and media companies, our next guest is leveraging his information technology expertise to drive patient engagement and create a frictionless and more meaningful patient experience. Michael Boerner, CEO of Engage Technologies Group, joins us to discuss how he and his team are removing barriers to patient education through short-form video-based technology that transfers relevant knowledge from diagnosis to post-op instructions. In addition, Michael also shares how Engage's efforts to close knowledge gaps are producing a strengthened relationship between providers and their patients. Join us for this exciting conversation to discover how Michael and his team are transforming lives by removing barriers to patient education. Let's go! Episode Highlights: Why scaling information and wisdom is what drives Michael to change people's lives for the better. How Engage delivers information to patients in a timely and engaging manner. What the patient and provider experience has been like for Engage. Michael's prediction of the healthcare industry will move toward trusted automation. About Our Guest: Michael Boerner is the Founder and CEO of Engage Technologies Group, Inc., and has over 25 years of experience founding and leading technology & media companies. He is an entrepreneur responsible for innovating a number of short-form video-based enterprise technologies enabling data-driven video personalization & mass constituent engagement. Michael is a TEDMED 2013 Frontline Scholar, as well as a national award-winning film and video producer and technologist. He led one of the first hospital pilots to use the iPad for patient engagement the day the iPad debuted on April 3rd, 2010 at the Disney Children's Hospital in Orlando. His company's clients have included: Johnson & Johnson, CVS, Ford, Samsung, UnitedHealthcare, DePuy, Covidien, UPMC, St. Luke's Health System, K12, Blue Cross Blue Shield MN, and the Ken Blanchard Companies, to name a few. In October 2009, Michael presented a new approach to patient engagement at the prestigious Health 2.0 Conference in San Francisco and won the award for medical technology innovation in the crowded Launch! competition. Mr. Boerner was appointed by the Governor of Idaho to the Governor's Coordinating Council for Families and Children and served on the board of directors for the National Institute of Marriage, a non-profit entity started by best-selling author, Gary Smalley, to help serve marriages facing crisis. Mr. Boerner has appeared nationally on CNN, Fox News, ABC Radio Network News, as well as numerous press articles covering his media and technology innovations. Michael's first press coverage for entrepreneurial creativity appeared on the front page of a Gannett Newspaper when he was 14. Links Supporting This Episode: Engage Technologies Group website: https://engagetg.com/ (CLICK HERE) Michael Boerner LinkedIn page: https://www.linkedin.com/in/michael-boerner-828a491/ (CLICK HERE) Michael Boerner Twitter page: https://twitter.com/michaelboerner (CLICK HERE) Clubhouse handle: @mikebiselli Mike Biselli LinkedIn page: https://www.linkedin.com/in/mikebiselli (CLICK HERE) Mike Biselli Twitter page: https://twitter.com/mikebiselli (CLICK HERE) Visit our website: https://www.passionatepioneers.com/ (CLICK HERE) Subscribe to newsletter: https://forms.gle/PLdcj7ujAGEtunsj6 (CLICK HERE) Guest nomination form: https://docs.google.com/forms/d/e/1FAIpQLScqk_H_a79gCRsBLynkGp7JbdtFRWynTvPVV9ntOdEpExjQIQ/viewform (CLICK HERE)
Michael Boerner, Founder and CEO of Engage Technologies Group, Inc. He has over 25 years of experience founding and leading technology & media companies and is an entrepreneur responsible for innovating a number of short-form, video-based enterprise technologies enabling data-driven video personalization & mass constituent engagement. Michael's clients have included: Johnson & Johnson, CVS, Ford, Samsung, UnitedHealthcare, DePuy, Covidien, UPMC, St. Luke's Health System, K12, Blue Cross Blue Shield MN and the Ken Blanchard Companies, to name a few.Michael and Michael explore the latest offering from Engage Technologies which transforms how patients get education prior to a procedure. The tool leverages text in a new way to make opting in to the education seamless. Leveraging the tool, the provider can ensure the patient has completed the education prior to the procedure, thus reducing cancellations and improving outcomes. The tool remains available for the patient and their care givers to reference throughout their journey to recovery. It is a stark change from today where a patient is given rushed and hurried instructions they often forget.#changehealthcare #Improvepatientoutcomes
In this episode, I spoke to an innovator in Mobile Intelligence - Engage Technologies Group Inc - Founder and CEO - Michael Boerner. He is blazing a trail with some truly exciting technology to enhance operational workflows across industries and particularly in healthcare!Michael Boerner is the Founder and CEO of Engage Technologies Group, Inc., and has over 25 years of experience founding and leading technology & media companies.He is an entrepreneur responsible for innovating a number of short-form, video-based enterprise technologies enabling data-driven video personalization & mass constituent engagement.Michael's clients have included: Johnson & Johnson, CVS, Ford, Samsung and UnitedHealthcare, DePuy, Covidien, UPMC, St. Luke's Health System, K12, Blue Cross Blue Shield MN and the Ken Blanchard Companies, to name a few.He was appointed by the Governor of Idaho to the Governor's Coordinating Council for Families and Children as well as served on the board of directors for the National Institute of Marriage, a non-profit entity started by best-selling author, Gary Smalley, to help serve marriages facing crisis. Michael has appeared nationally on CNN, Fox News, ABC Radio Network News, as well as numerous press articles covering his media and technology innovations. Michael's first press coverage for entrepreneurial creativity appeared on the front page of a Gannett Newspaper when he was 14.https://engagetg.com/
Metal-on-metal artificial hip devices have been available for more than twenty years. Years ago, product manufacturers thought that metals like titanium, cobalt, and chromium used in the construction of artificial hips would last a lot longer than the regular shelf life of other artificial hips using plastics and ceramic materials, particularly for athletes and active people. Unfortunately, those metals have caused many problems, like metallosis, which happens when metal particles grind away from the artificial hip and leach into the bloodstream and surrounding tissue, causing pseudotumors, high levels of metal in the blood, and other problems. Various manufacturers developed different metal-on-metal artificial hips. In most cases, it did not go well for the thousands of patients who had hip replacement surgery. Hundreds of thousands of those patients have subsequently become plaintiffs in litigation against all those companies. In this podcast conversation, Attorney Clay Hodges updates on the Smith & Nephew Birmingham hip litigation, which has been going on for several years. The litigation has become quite active lately, with many new cases filed. Stay tuned to hear the details, and find out what it could mean for you if you have had a hip replacement done in the last ten to fifteen years. Show highlights: Smith & Nephew first began to sell the Birmingham Hip Resurfacing device in the United States in 2006. The different types of surgery required for the two Birmingham hip systems at play in this litigation. With the first type of Birmingham Hip Resurfacing System, Smith & Nephew provided the resurfacing components only. That was approved by the FDA in 2006. Smith & Nephew described the Birmingham Hip Resurfacing System as a good choice for more active patients because the company said it would last longer than other systems. While companies like Zimmer and DePuy were having trouble with their own MoM artificial hips, Smith & Nephew claimed that its Birmingham hip was a different type of metal hip implant that could be distinguished positively from those causing problems. The Birmingham hip components used as part of a total hip replacement were the second type of Smith & Nephew hip that has led to litigation. The S&N Birmingham THA components did not get FDA approval. All brands of metal-on-metal hips have caused problems, injuries, and symptoms. That is why they are mostly no longer in use today. Smith & Nephew lawsuits began for similar problems occurring with the Birmingham hip components soon after Zimmer and DePuy started dealing with litigation for their metal-on-metal hip systems. The results of the S&N bellwether trial that took place for one of the first Smith & Nephew cases last June. What does this litigation mean for you if you have had a hip replacement done in the last ten to fifteen years? Links and resources: If you think you may have a possible S&N Birmingham case, call Clay at 919-546-8788. Note: The information in this podcast episode is for informational purposes only. All the information in this episode was derived from media reports, public court filings, and other publicly available resources. Any opinions presented are mine alone. The information provided is not intended to be and should not be construed as legal or medical advice.
In this episode, two senior orthopedics executives at DePuy Synthes walk us through the company's growing portfolio. First, Rajit Kamal, worldwide president, sports medicine and shoulder reconstruction, lays out the opportunity for the growing shoulder market and explains what the INHANCE Shoulder System offers to surgeons. He also details what it will take for ortho companies to grow the shoulder market. Later, Andrew Ekdahl, Worldwide President, Joint Reconstruction, updates us on the company's VELYS surgical robotic system. He explains how new digital and robotic tech will change the orthopedics industry. Instead of Newmarker's Newsmakers, this week host Tom Salemi will review the most listened to DeviceTalks Weekly Episodes of 2021. We'll also announce upcoming news in in-person conferences, digital meetings and podcasts – including a NEW podcast powered by DeviceTalks. Subscribe to all these podcasts at most major podcast platforms.
In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Andrew Ekdahl, worldwide president of joint reconstruction at DePuy Synthes. He offers insight on the company's approach to knee replacement, blending a number of technologies to achieve a restoration. Ekdahl also speaks to the impact newer innovations, such as robotic-assisted surgical technologies and data driven solutions, have on knee implants. Specifically, the following questions are addressed.I understand DePuy is taking a different approach to total knee replacement. Instead, it's being looked at as knee restoration. Can you explain what that is and why the differentiation in language?How is data driven technologies being used to help with this mission?What's happening in terms of implant development? Are the implants changing to meet with this effort?To further enhance this mission to restore the knee, how is personalized medicine (a term we hear often) playing a role here?How does this effort meet with the needs (and wants) of surgeons? Is this speeding up surgical procedures?What about the instrumentation? Any changes and/or advancements in that space?What is this leading to? Where is DePuy headed in terms of the knee, joints, or the larger orthopedic space?Listen to this episode and see what you think of DePuy's knee restoration strategy. If you'd like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.
Nick DePuy is a defender for the LA Galaxy. After being selected first round, 19th overall during the 2017 MLS Super Draft by the Montreal Impact, he's had to navigate a few team changes and setbacks to get to this point in his career. Topics : - Committing to the highest level - Navigating new experiences - Overcoming unseen obstacles - Tuning Out The Negatives - Back to the basics - Meditation & Mindfulness Connect with Nick! Instagram : @NickDePuy Check out the LA Galaxy! Instagram : @LAGalaxy Get hydrated with Liquid I.V.! Save 25% every order using my code : THEBEARDEDMAN Link Sign up for the Stay Dialed In Newsletter! You wanna help blow this podcast up? GREAT! Here's how: Leave a 5 star review on the podcast app with your hot take of the show Share out the episode on your IG story tagging me @Bobbbaaaay —- Follow The Bearded Man! Instagram : @Bobbbaaaay YouTube : @BobbyHobert Twitter : @Bobbbaaaay Website : ItsTheBeardedMan.com
Notes:These notes include affiliate links.Kelly has authored and self-published two YA Fantasy novels (The Witches of Athium, The Coven of Athium) in her The Athium duology. In May of 2021, she released a book titled “Affirmations for Writers: A Guide to Nurturing Your Creative Life with Affirmations” that helps guide creatives through the daily process of managing the mental and emotional side of writing - and also teaches how to approach creating your own personal affirmations. She's also currently working on a steampunk murder mystery series.Kelly posts regularly on Instagram often with some of her personal affirmations as well as glimpses into her personal and writing life. You can connect with her and her work on Instagram @KLDepuy and on Facebook at @kldepuy. The eBook version of The Witches of Athium is now available for free! You can find the links here: https://books2read.com/u/3RnwXY An unpublished bonus chapter from The Witches of Athium is also available with a signup for her newsletter. Here is that link: https://landing.mailerlite.com/webforms/landing/e1t2l2 Books Mentioned:The Witches of Athium (The Athium Duology Book 1) by K L DepuyThe Coven of Athium (The Athium Duology Book 2) by K L DepuyAffirmations for Writers: A Guide to Nurturing Your Creative Life with Affirmations by Kelly DepuyLittle House in the Big Woods by Laura Ingalls WilderSong of the Lioness series (4 book series) by Tamora PierceMusic from: https://filmmusic.io ‘Friendly day' by Kevin MacLeod (https://incompetech.com) Licence: CC BY (https://creativecommons.org/licenses/by/4.0/)
This episode of the DeviceTalks Weekly Podcast draws from two realities First, Russell Powers, worldwide president, shoulder reconstruction, sports medicine, and spine at DePuy Synthes details how the company's new Inhance Shoulder system will help the company grab market share in the increasingly competitive space. Later, we meet Dr. Justin Barad, CEO of OssoVR, on his own turf, conducting an interview in OssoVR's virtual reality training platform. In the interview, Dr. Barad demonstrates why virtual reality training help alleviate the growing demands on surgeons while also improving performance. Chris Newmarker, executive editor of life sciences, identifies this week's Newmarker's Newsmakers including Abbott, Medtronic, and Vicarious Surgical. Senior editor Danielle Kirsh also shares her insights on the ongoing Theranos trial, including damaging testimony from General James Mattis. Subscribe to this podcast on all major channels!
This week we welcome Traci DePuy, Head of Global Events at Salesforce.org, to the podcast! We talk about what it takes to be a great leader, staying positive in challenging times, and organizing work streams to build a successful hybrid event. And, we try to answer the question: What's the best way to motivate a team? You don't want to miss this episode of Meeting Minds!
On this episode of the 19th Hole - the guys recap the thrilling action at the PGA Championship and Phil Mickelson's historic victory. The boys survived co-host Andrew's DePuy's wedding weekend - the stories that they share on this show. Tony Leodora checks in from the road in his monthly Tee Time with Tony segment. Where will be he be this time? See omnystudio.com/listener for privacy information.
Summary:In today's episode, I talk with Alli DePuy and Kathleen Dent, and how they partnered to co-own Inspired Classroom. We talk about what is Inspired Classroom and how it brings learning to life. We discuss their mentor inspired software and service to connect students, educators and experts.We talk about how they met and their background. Kathleen and Alli talk about what keep them going and the unintended positive impacts. They explain the driving force behind Mentoric. They dive into the types of content and the dynamic vs static. They talk about different uses of the software and how it can track student engagement and development. We discuss the future of Inspired Classroom, and how they are trying to raise funds for the first time. Here's a closer look at the episode:How Alli and Kathleen metAlli and Kathleen's Background The unintended impacts and consequences What is MentoricThe driving force behind MentoricThe dynamic content vs static Tracking student engagement and development The future of inspired classroomRaising funds for the first time Resources:Website: https://www.inspiredclassroom.com/Linkedin: https://www.linkedin.com/company/inspiredclassroom/Twitter:https://twitter.com/InspiredClassesFacebook: https://www.facebook.com/InspiredClassroom/MentroIC: https://icchallenge.org/
In today's episode, I talk with Alli DePuy and Kathleen Dent, and how they partnered to co-own Inspired Classroom. We talk about what is Inspired Classroom and how it brings learning to life. We discuss their mentor inspired software and service to connect students, educators and experts. We talk about how they met and their background. Kathleen and Alli talk about what keep them going and the unintended positive impacts. They explain the driving force behind Mentoric. They dive into the types of content and the dynamic vs static. They talk about different uses of the software and how it can track student engagement and development. We discuss the future of Inspired Classroom, and how they are trying to raise funds for the first time. Here's a closer look at the episode: How Alli and Kathleen met Alli and Kathleen's Background The unintended impacts and consequences What is Mentoric The driving force behind Mentoric The dynamic content vs static Tracking student engagement and development The future of inspired classroom Raising funds for the first time Resources: Website: https://www.inspiredclassroom.com/ Linkedin: https://www.linkedin.com/company/inspiredclassroom/ Twitter:https://twitter.com/InspiredClasses Facebook: https://www.facebook.com/InspiredClassroom/ MentroIC: https://icchallenge.org/
In today's episode, I talk with Alli DePuy and Kathleen Dent, and how they partnered to co-own Inspired Classroom. We talk about what is Inspired Classroom and how it brings learning to life. We discuss their mentor inspired software and service to connect students, educators and experts. We talk about how they met and their background. Kathleen and Alli talk about what keep them going and the unintended positive impacts. They explain the driving force behind Mentoric. They dive into the types of content and the dynamic vs static. They talk about different uses of the software and how it can track student engagement and development. We discuss the future of Inspired Classroom, and how they are trying to raise funds for the first time. Here's a closer look at the episode: How Alli and Kathleen met Alli and Kathleen's Background The unintended impacts and consequences What is Mentoric The driving force behind Mentoric The dynamic content vs static Tracking student engagement and development The future of inspired classroom Raising funds for the first time Resources: Website: https://www.inspiredclassroom.com/ Linkedin: https://www.linkedin.com/company/inspiredclassroom/ Twitter:https://twitter.com/InspiredClasses Facebook: https://www.facebook.com/InspiredClassroom/ MentroIC: https://icchallenge.org/
This episode is part of a series titled A Praying Church. Bob Allums, Director of seeJesus's A Praying Life Ministry, joins Paul and Liz Voboril for this series. Today they're joined by guest Maresa DePuy, Prayer and Women's Mentoring Director at Life Park Church near Charleston, SC. "One woman named Mary started praying by herself behind the scenes, and I came in about a year later and joined her. We would pray Sunday mornings during services in the back of the church interceding for the prayer needs. One by one, God sent us other ‘Annas’ in the church and so we were a small cluster of praying women for a few years as the story began…" “I do think it's a temptation that you can fall into as a prayer team leader to just kind of force prayer into the church. It's really got to be done by the Spirit..." "The prayer meeting becomes an incubator or a greenhouse where all of this faith just begins to bloom. So you leave more confident, expecting that the work of God is going to go forth in some way and the exciting part is you don't know how. You come back to that next prayer meeting with a posture of celebration and thanksgiving. What we try to do in our in our staff meetings and our community prayer services is celebrate what we see God doing in response to our weak, broken, but Spirit-filled prayers."
Why Should We Trust a Vaccine from a Condom Maker? Richard Gale and Gary Null PhD Progressive Radio Network, March 5, 2021 For decades, according to a Guardian article, “consumers worldwide have named the $347 billion pharmaceutical behemoth Johnson and Johnson (J&J) as one of its most trusted brands.” From its humble beginnings in the 1880s, making cotton gauze dressings and eventually band aids, baby powder and shampoo, J&J has expanded into one of the most powerful multinational pharmaceutical and medical device companies in the world. In 1959, it entered the world of Big Pharma as a leading player after succeeding in getting Tylenol approved as an over-the-counter drug. Shortly thereafter J&J commenced with a flurry of acquisitions to increase its product line, which included Neutrogena, Cordis, DePuy, Janssen Pharmaceutica and Centocor. Today, in most American home medicine cabinets one will find a popular J&J product: Listerine, Tylenol and Benadryl, Neutrogena skin cream, Rogaine, Neosporin antibacterial ointment, or Destin to treat diaper rashes. Now, people are eager for J&J’s “one shot and you’re done” Covid-19 vaccine despite health officials’ fears it may be less effective than Moderna’s and Pfizer’s mRNA competitors. Nevertheless, vaccination centers and pharmacies are racing to get their hands on the new adenovirus-based vaccine. And as we will further note below, this is from a company that has absolutely no past experience in vaccine development and manufacturing. However, we need to seriously challenge J&J’s reputation. A 2019 report by the British intelligence firm Alva has noted that J&J’s reputation has sunk dramatically during the past years, from 9th place among 58 major pharmaceutical firms to 57th. Certainly, this is not a company with a clean ethical record. A review of J&J’s rap sheet over the past three decades presents a dire and contrary image that should lead us to question the company’s claims about its Covid-19 vaccine given the lucrative market the pandemic has created for the most aggressive medical corporations. Similar to its equally over-sized competitors Glaxo, Merck and Pfizer, J&J too has had to pay out billions of dollars over the decades for civil settlements and criminal activities. As the pharmaceutical giant receives applause across the mainstream media for the release and FDA emergency approval for its Covid-19 vaccine, Brazil’s Public Prosecution Service started an investigation into J&J’s antitrust activities under the Foreign Corrupt Practices Act (FCPA) for “possible improper payments in its medical device industry.” This was part of an FBI bribery scheme investigation that included Seimens, General Electric and Philips acting as a larger cartel to illegally payoff government officials in return for securing contracts with Brail’s national health programs. The charges also include price gouging, inflating prices up to 800 percent the market price to cover bribes. This is not the first time J&J has violated FCPA laws. In 2011, J&J was charged by the Department of Justice with conspiracy for paying off Greek doctors to advance its product sales. The SEC also charged civil complaints. The company had to pay out a $70 million penalty for buying off officials in Greece, Poland and Romania. In 2010, an executive for J&J’s subsidiary DePuy was sentenced to a year in prison for corrupt payments to physicians within the Greek national healthcare system. As one of the world’s leading medical device companies, J&J has had its share of recalls for faulty products including contact lenses and hip implants In 2013, it paid nearly $2.5 billion to compensate 8,000 recipients for its flawed hip implants Again in 2016, another $1 billion was awarded to plaintiffs injured from this device. One particular dubious activity the company became involved with in 2008 was to launch a “phantom recall.” When its Motrin IB caplets were discovered to not properly dissolve, it hired outside contractors to buy up store supplies in order to avoid making public declaration. No one would have known of this activity and it would have gotten past the eyes of FDA inspectors had the deception not been exposed during a Congressional investigation. Other major J&J lawsuits and recalls for faulty products include: 1995 - $7.5 million fine for destroying documents to cover up an investigation into wrongful marketing of its Retin-A acne cream to remove wrinkles 1996 – An undisclosed settlement on false claims over condom protection claims to protect against HIV and other STDs. 2000 – J&J’s subsidiary LifeScan was found guilty for selling defective blood glucose monitors and failed to inform the FDA. All total, $105 million was paid out. 2001 – Paid out $860 million in a class action lawsuit for misleading customers about prematurely discarding its 1-Day Acuvue soft contact lens. J&J recommended they should only be worn once although it was discovered the lenses were no different than the regular Acuvue lens that would last for two weeks 2010 - $81 million settlement for misbranding its anti-epileptic drug Topamax to treat psychiatric disorders and hiring outside physicians to join its sales force to promote the drug for unapproved conditions. The following year, J&J paid $85 million for similar charges against its heart drug Natrecor 2011 – Several of its baby products were discovered to contain carcinogenic ingredients 2013 – The US Justice Department charged the company $2.2 billion in criminal fines for marking its autism and anti-psychotic drug Risperdal for unapproved uses. Forty-five states had filed civil lawsuits against J&J in the scandal Risperdal is horrendous drug that contributes to rapid weight gain and a condition known as gynescomastia, irregular enlarged breasts in men. Semmelweis reports that J&J’s subsidiary Janssen also had an aggressive campaign to market its use in children with behavioral challenges. Other serious adverse effects from Risperdal reported by the FDA include diabetes mellitus, hyperprolactinaemia, somnolence, depression, anxiety, psychotic behavior, suicide and death. The company’s legal problems over Risperdal do not appear to have ended. In October 2019, a Philadelphia jury awarded a man $8 billion in punitive damages for failing to warn that the drug could cause young men to grow breasts. Other recent suits include litigation over its blood thinner Xarelto risks of internal bleeding, and a $775 million settlement to 25,000 plaintiffs. 2016 - Two women were awarded $127 million in damages for the talc in its J&J Baby Powder causing ovarian cancer. Later, over 1,000 similar cases came forward. During the trial it was discovered that J&J suspected a link between talcum and ovarian cancer back in the 1970s. A Missouri verdict fined the company over $4 billion but it was later reduced to $2.1 billion. A New York Times investigation into internal J&J memos uncovered evidence that the talcum powder may have contained asbestos. These cases continue. In July 2019, J&J made efforts to dismiss 14,000 lawsuits over the talcum-cancer risk. More recently, J&J has been in the spotlight for its role in contributing to the deadly opioid crisis. The company holds the patent for a unique strain of opium poppy commonly named Norman. It is the leading provider of the opioid for Purdue Pharma’s painkiller OxyContin. An Oklahoma court ordered a $465 million fine. This opened the door for other states to follow suit. To fully realize how insane the system is, the half a billion dollar civil fine was good news on Wall Street, which anticipated the verdict would be in the billions of dollars. Consequently, J&J’s stock rose 2 percent after the judge’s ruling. And despite J&J being Purdue’s major supplier, and a major contributor in the US’s opioid epidemic, the latter was forced to file for bankruptcy due to mounting lawsuits for overdose deaths. Finally, we might ask why a 140 year old company, with no history whatsoever in vaccine development, has now become among the heroes in the immunological war against Covid-19? J&J is not a household name in the vaccine industry. It is utterly absent, let alone ranks among the world’s 20 major vaccine makers. Among the 53 vaccines for other infections approved and licensed by the CDC, not one is manufactured by the nation’s leader in mouthwash and baby powder. It is therefore no surprise that the company had to partner with Merck to manufacture its Covid vaccine to meet demand. It has no history or expertise in this medical field. However, the Covid pandemic is a cash cow for the drug industry’s taking. Bernstein market analyst Ronny Gal predicts Covid-19 vaccine sales will reach $40 billion this year. A more realistic figure is likely higher since together Moderna and Pfizer project their revenues at $32 billion. Then there are the other major vaccines by AstraZeneca, J&J and Novavax entering the competition. According to the London School of Hygiene and Tropical Medicine’s vaccine research tracker, over 200 vaccines against Covid-19 are in development worldwide. It is an enormous pumpkin pie and everyone in the medical universe wants a slice from it. So why shouldn’t we expect a non-vaccine player such as J&J to be eager to leap into the frenzy? Finally, there is a disturbing question that we have no certain answer for. How is it that a drug and household health product company, with no prior history in vaccine development, can develop and rush to market its first vaccine against a viral strain that was only identified 14 months ago? Developing a vaccine requires many years and necessitates the establishment of an R&D infrastructure vastly different than conventional drug development. The other major companies developing Covid-19 vaccines have been in the business for decades. But not J&J. There is something more to this story that demands investigation. And if the company’s long rap sheet offers any warning, it is that we must be wary of any claims J&J publicly states about the efficacy and safety of its products. Especially when the pandemic promise to increase the profits of numerous shareholders.
The pandemic has accelerated innovation in many ways but the physical pressures on entrepreneurs, innovators and engineers is very real. In this episode of the DeviceTalks Weekly Podcast, a panel representing early-stage and tech transfer efforts explain how they're helping individuals and young companies work through the unique challenges of the time, including: *Finding capital *Working with corporates *Understanding opportunities in a changing healthcare market *Are there silver linings Guests include Jennifer McCaney, PhD,,co-executive director, UCLA Biodesign Jackie Mejia, PhD, director, gBeta Medtech Scott Morley, director, office of economic partnerships, University of Pittsburgh This conversation is a condensed version of our Jan. 19 DeviceTalks Tuesday. Go to DeviceTalks.com to watch the entire presentation. Co-host Chris Newmarker, executive editor of MassDevice, also shares his top 5 stories of the week, aka, NewmarkersNewsmakers. The big news belongs to DePuy, Philips, Boston Scientific, Transenterix and President Biden.
Oral Arguments for the Court of Appeals for the Federal Circuit
DePuy Synthes Products, Inc. v. Veterinary Orthopedic Implant
Oral Arguments for the Court of Appeals for the Federal Circuit
MedIdea, L.L.C. v. DePuy Orthopaedics, Inc.
First Supply's director of sales and marketing talks old customers, new business challenges, and seeking to elevate both attitude and altitude. Read the article.
150 pupils from four Cork primary schools recently attended DePuy Ireland Unlimited Company’s (“DePuy Ireland”) first-ever Virtual STEM Academy Programme event. The event marks the completion of DePuy Ireland’s two-year STEM Pilot Outreach Programme and launches the Virtual STEM Academy Programme for the 2020/21 academic year. DePuy Ireland is part of the Johnson & Johnson DePuy Synthes Family. The STEM Academy Programme is designed to inspire and encourage children to engage in future studies and careers in science, technology, engineering, and math-related fields. Over the past year, the programme has reached over 10,000 Irish primary school students, teaching STEM-related subjects including robotics, 3-D printing, sustainability, and virtual reality as part of our Lego Mindstorms, Dash, and Dot Robotics, and 3-D printing programmes. This year, the impact of Covid-19 has seen DePuy Ireland transform its STEM Academy Programme to a virtual format. A dedicated team of DePuy Ireland volunteers lead by Susan Dunlea from DePuy Ireland’s Engineering, Science & Technology Group have prepared a bank of virtual lessons for the outreach programme. In addition, the team has also allocated time for online training and assistance for schools and teachers engaging with the programme. DePuy Ireland has also provided schools with equipment required to run their own STEM Academy Programmes, including 3D printers and consumables, wonder packs for Dash and Dot robotics, and IT equipment. Teachers and pupils of Cork schools, Scoil Bhríde, Rathcormac; Scoil Mhuire, Ballincollig, Watergrasshill National School, and St Paul’s School, Montenotte, attended the Virtual STEM Academy Programme launch event, which included a video event featuring testimonials of past participants, principals, teachers and volunteers. Speaking about the Programme, Mairéad Ní Mhurchú, Principal of Scoil Mhuire, Ballincollig, Co. Cork said “The students are really excited to be involved in the STEM Academy Programme this year. The programme is a great tool that allows our teachers to encourage students to engage in innovative thinking and explore the possibilities associated with a career in STEM.” Speaking about DePuy Ireland’s efforts to continue STEM outreach programmes virtually, Gary Clerkin, Global Leader Manufacturing, Engineering, Science & Technology, DePuy Ireland Unlimited Company, said “At Johnson & Johnson, we recognise the importance of creating future generations of life-changing scientists and engineers. So far this year, we’ve reached over 10,000 children in a safe and socially distanced way. It is important for us to show all children, regardless of gender, socio-economic background and ethnicity, that a future in STEM is an exciting possibility and one that we’re committed to supporting.” More about Irish Tech News and Business Showcase here. FYI the ROI for you is => Irish Tech News now gets over 1.5 million monthly views, and up to 900k monthly unique visitors, from over 160 countries. We have over 860,000 relevant followers on Twitter on our various accounts & were recently described as Ireland’s leading online tech news site and Ireland’s answer to TechCrunch, so we can offer you a good audience! Since introducing desktop notifications a short time ago, which notify readers directly in their browser of new articles being published, over 50,000 people have now signed up to receive them ensuring they are instantly kept up to date on all our latest content. Desktop notifications offer a unique method of serving content directly to verified readers and bypass the issue of content getting lost in people’s crowded news feeds. Drop us a line if you want to be featured, guest post, suggest a possible interview or just let us know what you would like to see more of in our future articles. We’re always open to new and interesting suggestions for informative and different articles. Contact us, by email, twitter or whatev...
Oral Arguments for the Court of Appeals for the Sixth Circuit
Andrea Drake v. DePuy Orthopaedics Inc - 19-4075 ASR Hip Implant Products Liability
Joanne DePuy was an influential player in the Judgment of Paris...but that is not the most inspirational part about her. Wait until you hear her the rest of the story.
This podcast was recorded while taking shelter from heavy winds and freezing rain at Depuy's Spring Creek. Turner got a chance to sit down with his dad, Tom, and brother, Hayden, to talk about the days spent together and what makes fishing special to them. Head River Farms: https://www.headriverfarms.com/product/cbd-oil-1000mg/1?cp=true&sa=true&sbp=false&q=false Learn more about your ad choices. Visit megaphone.fm/adchoices
Today, we chat with Scott Ryan about his role with well-known local orthopedic company, Depuy Synthes, and the best spots to eat in Kosciusko County!
In uncertain times we seek out those that can shed some light on what our future might look like and how to stand strong. There is no one better at painting that vision than Aldo Denti the Group Chairman Deputy Synthes. Aldo Share with us his career and his inner guides he uses and shares with others to make the best choices for themself. We dive deep into his career and the ups and downs and the surprises along the way. We also dive into the changes the Covid pandemic will cause in our healthcare industry. We can't look at changes as all bad, there is a lot that will help make the needed changes that will heal our healthcare. If you have or know a college graduate have them tune in as Aldo donates his time to Florida State University to mentor and guide our future. Telehealth/digital health and sales rep access are two points that we cover and acknowledge will change but will give us new opportunities to provide more value. Please take the time to listen, this is one of my favorite interviews and well needed at this time.
In these uncertain times we search out for wisdom and vision in others to help us navigate these times. I could not think of anyone better that has navigated some tough situations, personally and professionally, to help bring some clarity to our medical device world. I'm proud to have the Company Group Chairman from DePuy Synthes, Aldo Denti, share his thoughts on career development, critical thinking in making changes to your career trajectory, and our future in the Covid aftermath. He shares some powerful thoughts on never underestimating oneself and take the choice to develop skills you don't have for the 2nd job after the one you are in. We discuss the top 3-4 areas where the commercial side of healthcare sales will be impacted, Rep Access is a key topic along with digital health and creating suites of IOT connected devices that communicate with each other to reach levels of efficiency to heal our healthcare. Once again, sit back and enjoy the ride, and listen to see if you can tell i'm at home recording this great interview.
GolfTalk Live visits Eagle Ridge GC in Lakewood, NJ for the first time ever. This is GolfTalk Live's first trip to New Jersey in 2020. In the "Product of the Month" segment, co-host Allen DePuy spoke with Justin Nogay of Peak Golf Fitness (https://online.peakgolffitness.com/). DePuy and co-host Tony Leodora interviewed Bill Golden, President of Golf Tourism Solutions in Myrtle Beach -- which is open for golf and for travel (http://golftourismsolutions.com/)! In another segment from the south, Tony spoke with Simone Bergese of Chateau Elan, just outside Atlanta, GA. See omnystudio.com/listener for privacy information. See omnystudio.com/listener for privacy information.
COG MERCHANDISE (SCARVES, T-SHIRTS, BUTTONS, COASTERS): http://www.cornerofthegalaxy.com/SHOP COG STUDIOS, Calif. -- How optimistic are you that the LA Galaxy are going to play this season? How would a season even look at this point? And remember, it's only been about three weeks, so we've got some room! Hosts Josh Guesman and Kevin Baxter are back to talk about the hurdles Major League Soccer faces when, and if, they restart the league this year. Will they have to move teams to South Dakota? Could the quarantine everyone in a couple of hotels and play games like crazy? Or will the league have to navigate hot spots and a patchwork of government regulations? We'll give you our best guesses at how they do all of that and what a respectable timeline looks like! Plus, Josh will update you on a brand new Galaxy initiative that will have you staying at home, but hopefully entertained! Finally, Josh will talk with Galaxy defender Nick DePuy. DePuy will speak about growing up a Galaxy fan, and what it means to play for his hometown team - even if it was for just two games this season. Plus, he'll talk about being asked to transition to a center back after coming into the league a striker! We've got an excellent quarantine show for you that's full of all the entertainment you need. But remember, Stay Home, Stay Safe, Wash Your Hands, and Don't Hurt Your Pelvis!
COG MERCHANDISE (SCARVES, T-SHIRTS, BUTTONS, COASTERS): http://www.cornerofthegalaxy.com/SHOP COG STUDIOS, Calif. -- How optimistic are you that the LA Galaxy are going to play this season? How would a season even look at this point? And remember, it's only been about three weeks, so we've got some room! Hosts Josh Guesman and Kevin Baxter are back to talk about the hurdles Major League Soccer faces when, and if, they restart the league this year. Will they have to move teams to South Dakota? Could the quarantine everyone in a couple of hotels and play games like crazy? Or will the league have to navigate hot spots and a patchwork of government regulations? We'll give you our best guesses at how they do all of that and what a respectable timeline looks like! Plus, Josh will update you on a brand new Galaxy initiative that will have you staying at home, but hopefully entertained! Finally, Josh will talk with Galaxy defender Nick DePuy. DePuy will speak about growing up a Galaxy fan, and what it means to play for his hometown team - even if it was for just two games this season. Plus, he'll talk about being asked to transition to a center back after coming into the league a striker! We've got an excellent quarantine show for you that's full of all the entertainment you need. But remember, Stay Home, Stay Safe, Wash Your Hands, and Don't Hurt Your Pelvis!
Trinity CathedralEpiscopal Diocese of ArizonaPhoenix, AZAlan Keith DePuy was born in Torrance, California on May 31, 1966 to the late Donald Clinton DePuy and Melva Lynn DePuy. Born with an incredible gift of music, Alan was – at nine years of age – already a guest organist for Crystal Cathedral, in Garden Grove, California, being in the spotlight of national television frequently. He continued to appear on “The Hour of Power” until the age of 18. He continued his formal music education at Chapman University, where he received his Bachelor of Arts degrees in Organ Performance and Piano Accompaniment. He studied with Dr. William Hall, Dr. Ronald Huntington and Dr. Tanya Fleisher while at Chapman University. He continued his education in the graduate Organ Performance program at Arizona State University, where he studied with Dr. Robert Clark and Dr. Kimberly Marshall. As a young organist, Alan played in numerous competitions and received four first-place honors in competitions sponsored by The American Guild of Organists. He also played concerts throughout the United States, Canada, Europe and Asia. Alan was called to make music, but specifically, he was called to make music for the church. He shared his gift with churches across the country that he served, including First Christian Church, Fullerton, California; St. Andrew’s Presbyterian Church, Newport Beach, California; Holy Family Cathedral, Orange, California; Trinity Cathedral, Phoenix, Arizona; St. Mark’s Cathedral, Seattle, Washington; St. Thomas Church, Coral Gables, Florida; and St. George’s Church, Germantown, Tennessee. Alan’s talent and musical ability were tremendous and unparalleled; his passion for great music was always reflected in his willingness to share his incredible musical gifts with everyone – and his desire to awaken the love of music in even the most neutral observer. As tremendous as were his musical gifts, they could not overshadow his love for all humanity: Alan loved unconditionally and cared for everyone around him; wherever he went, his arms were always open in love. Even as we celebrate that Alan has passed into Resurrection light, and into the nearer presence of our God, we grieve the loss of him as a loving friend and supportive colleague, and the loss of his tremendous talent in the Church and in the world. Alan is survived by his brother, Thomas DePuy, his nephew, Dylan DePuy, his sister-in-law, Susanne DePuy and many, many friends, colleagues, choir members and parishioners whose lives he touched in profound ways, whom he loved unconditionally, and who will always remember and love him.
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In late 2016, I was able to sit down with Kevin Sidow. At the time he was President & Chief Executive Officer for Moximed, and had been since 2008.Prior to his time at Moximed, Kevin was President & CEO for St. Francis Medical Technologies, a privately held, venture-funded company focused on developing innovative treatments for patients suffering from degenerative spinal disorders. In January 2007, St. Francis Medical Technologies was sold for $725 million to Kyphon, which was acquired by Medtronic later that same year.Previously, Kevin was the Worldwide President of DePuy, where he supervised the global orthopedic, spine, trauma, and sports medicine businesses, with annual revenue responsibility of over $3 billion dollars. Kevin holds a B.S. in Accounting from West Virginia University.Here are a few of the things we learned from Kevin:- How Kevin felt when Moximed’s first patient was treated with the Atlas System after 8+ years of research and development.- What makes the Atlas System different than other orthopedic knee implants.- How medtech professionals looking to take the next step in their career can utilize Kevin’s advice and learn from his meteoric rise to Worldwide President of DePuy.See more...
Travis Depuy of xMatters speaks to Leandro & Brian about how to leverage tools like xMatters to enable proactive alerting and remediation throughout your code life-cycle.
Travis Depuy of xMatters speaks to Leandro & Brian about how to leverage tools like xMatters to enable proactive alerting and remediation throughout your code life-cycle.
My guest this week is Gove Depuy, sustainability consultant, community-based planner, project leader and an advocate for bio mimicry. What are we talking about? Islands, and the growing idea that islands might serve as learning ecosystems for new ways of communing with the Earth we inhabit. It’s not an entirely new idea. In 1962, legendary author Aldous Huxley, wrote and published the book Island, as a utopian companion to his better known and more dystopian novel, Brave New World. Inspired by time spent in Bali, Huxley described a people living in harmony with nature. Today there’s a lot more traffic and a concerning amount of trash and plastic, but it’s still Bali – an island where animism and Hinduism blend to create a unique pact between humans in rhythm with the environment. I sat with Gove by the banks of one of Bali’s many picture-perfect rivers, adjacent to the Five Elements Retreat. It proved the perfect setting to talk about life in Bali, community-based projects, and ultimately, the promise of islands as a petri dish for exploring new, potentially more sustainable ways of living in the world. Amidst the thick, verdant jungle, cascading waterfalls and buzzing birds and insects, it’s hard to imagine we face a climate crisis of epic proportions. Yet, we do.
In this episode, you’ll hear Greg, Conor and Travis Depuy from xMatters discuss closed-loop APIs and how AI can be applied to see the holes in the cognitive blind spots of large enterprises. They look at how we can build durable DevOps teams and overcome variables within the natural process of skill acquisition. https://www.xmatters.com/ https://www.mthree.com/
Karen and Rob chat with American Olympic Eventer Mara DePuy. Mara tells us about her start in riding at the age of three years old. Years later she took her Young Rider horse to the Olympics! Mara tells how her perseverance with her hard to ride partner paid off! We are sure you will find her story inspirational! Mara's website:http://www.maradepuyeventing.com/?fbclid=IwAR0Ty3az7NbiXcNK-B6FNlVpu1bQBlQcGhSZfdv2CKGoJlACpi1pTPW0zOEMara's Facebook:https://www.facebook.com/pg/MaraDePuyEventing/about/?ref=page_internalRedingote Equeastrian:https://landing.redingoteequestrian.com/mleMajor League Eventing:https://www.majorleagueeventing.com/
TrackMy Solutions Podcast - Medical Device Implant Recalls - Pharmaceutical Drug Recalls
We interview Dermot from London about his Depuy ASR Hip System Recall. For more information, visit www.TrackMyImplants.com
This week on Red Business Jonathan Healy looks at the worlds of Marketing and Mentoring. He chats to Pat Kierans, founder and MD of Dyjaho and he meets Marguerite O'Sullivan of DePuy to chat about getting women back to the workplace.
This comic about archaeologists uncovering the secret history of pop culture took Warren Ellis and John Cassaday 10 years to complete. We discuss its interrogation of genre, intellectual property and history, in light of the cyclical nature of the comics industry some 20 years after the project started. Interested in the media we discussed this episode? Please support the show by purchasing it through our affiliate store: Planetary League of Extraordinary Gentlemen: Nemo Trilogy StormWatch Black Summer All-Star Superman New X-Men RED Transmetropolitan Castlevania Additional Resources: WHY PLANETARY RULES THE WORLD The cynical superheroics (and hopeful humanity) of Warren Ellis' Planetary Beautiful and Unique Snowflakes: Warren Ellis' 'Planetary' ‘PLANETARY': DIGGING UP THE BONES OF THE GENRE COMIC Telling Stories About Storytelling: The Metacomics of Alan Moore, Neil Gaiman, and Warren Ellis
Nelson’s Spring Creek flows from the hills of Paradise Valley, just south of Livingston, Montana, and into the Yellowstone River. It’s only miles away from DePuy and Armstrong spring creeks, two other amazing fisheries, but Nelson’s is something extra special. In this episode, Dave interviews Steve about one fine day on Nelson’s Spring Creek. Since … Continue reading "S3:E50 One Fine Day on Nelson’s Spring Creek" The post S3:E50 One Fine Day on Nelson’s Spring Creek appeared first on 2 Guys and A River.
Nick Beauregard and Bryan Depuy are friends who decided to collaborate to develop a video game. Nick is a professional programmer and Bryan is an artistic type who got into programming to c0-create the game Bit Rat. I interviewed them at their booth at Magfest 2018. 0:50 – The developers talk about their game Bit … Continue reading Game developers Nick Beauregard and Bryan Depuy interview →
This week, we recap Texas Monthly's Whiskey Affair, which recently drew more than 700 eager whiskey tasters to Houston to sample different spirits from more than 30 distillers. The Texanist is our guide into Texas whiskey and it's 3 ingredients: History, Science and Passion.
It's our Book of the Month episode for July with the spotlight shining rightfully on Planetary by Warren Ellis, John Cassaday, and Laura Depuy. Plus, we announce our next themed episode.
Our podcast host today Robert Hossary, General Manager NSW/ACT at The American Chamber of Commerce discusses 'Authentic Leadership' with guest Gavin Fox-Smith, Managing Director at Johnson & Johnson Medical ANZ and AmCham Governor. Mr Fox-Smith joined Johnson & Johnson Medical Australia/NZ in 1997 as a Regional Business Director and in February 2012 was appointed Managing Director for Global Surgery and Johnson & Johnson Medical ANZ. Over the past 15 years Gavin has held leadership roles in Sales, Marketing and General Management across Ethicon, EES, DePuy and Cordis. The ongoing problems in business leadership in the past has underscored the need for a new kind of leader in the twenty-first century: the authentic leader. You also do not have to be at the top of your organization. Anyone can learn to be an authentic leader. The journey begins with leaders understanding their life stories. Authentic leaders frame their stories in ways that allow them to see themselves not as passive observers but as individuals who learn from their experiences. These leaders make time to examine their experiences and to reflect on them, and in doing so they grow as individuals and as leaders. Authentic leaders also work hard at developing self-awareness through persistent and often courageous self-exploration. Denial can be the greatest hurdle that leaders face in becoming self-aware, but authentic leaders ask for, and listen to, honest feedback. They also use formal and informal support networks to help them stay grounded and lead integrated lives. Thank you for your continued support of this podcast series. Please continue to let us know how we can improve this service for you by sending an email to podcast@amcham.com.au
Debbie Jo DePuy just recently finished her first Ironman 70.3 at Ironman Haines City, Florida. Debbie is a wife, a software coordinator and a mom of 2 high-school age boys. Debbie's background is as a swimmer. She started swimming when she was 5 and swam through college. She is a 7 time all-American swimmer. We talk about the decision to choose a race close to home in order to make it affordable. We talk about the resources she used to prepare for the race. Jenkins house of pain triathlon group, You Tube videos, Lightfront Striders and St. Cloud Mom's Run this Town and Women for Tri on Facebook. Her biggest challenge was time management. We talk about how she got creative to juggle her training and her life. We chat about being nervous to make the jump to clipless pedals and aerobars. Debbie shares that she really thought the race briefing was the most beneficial part of her pre-race check in. We talk about the benefits of being familiar with a race course and how you can never be sure what the weather will be like on race day. We talk about the actual race of Ironman 70.3 Haines City. Since Debbie's background is as a swimmer she swam 1.2 miles without a wetsuit in 35 minutes. Zoom zoom! Debbie shares what it was like to get encouragement from other triathletes on the bike course. Debbie battled IT Band issues while training and she tells us how she managed the run with that lagging injury. Debbie says, "No matter how your race goes always finish as hard as you can." We talk about what she would do differently with her training now that she's completed the race. Her goal is to complete a full Ironman before she turns 45. The day that we recorded the interview Debbie raced St. Anthony's triathlon and won her age group! Congratulations Debbie! Thank you for being a guest on the Mile after Mile Podcast and I look forward to seeing what great things you do coming up. Be sure to check out Amy's adventures at www.amysaysso.com
Stay Connected: http://www.audiobooks.com/podcast | email: podcast@audiobooks.com Ever wonder what it takes to create an audiobook? Wonder no more because on this episode we talk with Brian DePuy, the sound engineer at Audiobooks.com! From pages to narrator to audiobook app, Brian give us an inside look into the process of creating an audiobook from the sound engineering aspect. After all it's the SOUND that brings us our favorite audiobooks to life. Play the episode now to hear all about it. This Episode Covers: What goes into creating an audiobook How sound really shapes the story Reading vs Performance Brian's recommendation for getting the full listening experience What's exciting the Audiobooks.com team and lots more! Show us some love! Tweet this episode: http://ctt.ec/3eLZ5 Subscribing, rating and reviewing the show: iTunes Resources Mentioned RECordio App Studio Headphones: http://amzn.to/1hIIgXa | http://amzn.to/1LgdTkE
Back in August of 2010, Johnson & Johnson and DePuy announced the worldwide recall of parts used for hip replacements. Studies pointed to an unusually high rate of revision surgeries connected to the devices. On this edition of Ringler Radio, host Larry Cohen and Attorney Navan Ward, Jr., a Shareholder at the Beasley Allen law firm, take a look at the DePuy Hip Replacement Recall and the litigation surrounding DePuy.
Background: Low-contact-stress (LCS) mobile-bearing total knee arthroplasty (TKA) (Johnson & Johnson, New Brunswick, NJ; previously: DePuy, Warsawa, USA) provides excellent functional results and wear rates in long-term follow-up analyses. Radiological analysis shows radiolucent lines (RLL) appearing immediately or two years after primary implantation, indicative of poor seat. Investigations proved RLL to be more frequent in uncemented TKA, resulting in a consensus to cement the tibial plateau, but their association with clinical findings and patients discomfort and knee pain is still unknown. Methods: 553 patients with 566 low-contact-stress (LCS) total knee prostheses were screened for continuous moderate knee pain. We compared tibial stress shielding classified by Ewald in patients suffering from pain with a matched, pain-free control group on blinded X-rays. We hypothesized a positive correlation between pain and radiolucency and higher frequency of such radiolucent lines in the most medial and most lateral zones of the tibial plateau. Results: Twenty-eight patients suffered from knee pain in total. Radiolucencies were detected in 27 of these cases and in six out of 28 matched controls without knee pain. We could demonstrate a significant correlation of knee pain and radiolucencies, which appeared significantly more frequently in the outermost zones of the tibial plateau. Conclusion: Our findings suggest that radiolucent lines, representing poor implant seat, about the tibial plateau are associated with knee pain in LCS patients. Radiolucencies are observed more often in noncemented LCS, and cementing the tibial plateau might improve implant seat and reduce both radiolucent lines and associated knee pain.
Medizinische Fakultät - Digitale Hochschulschriften der LMU - Teil 06/19
Einleitung: In der operativen Versorgung von Frakturen der Tibia ist nach heutigem Standard die Marknagelung Methode der Wahl. Der neu konzipierte Titan US-Nagel Depuy ACE Aim Dynamic weist einige design- und funktionsspezifische Besonderheiten im Vergleich zum vorherigen Modell auf. Hierzu zählen die Bohrung des Nagels für die Verwendung von Führungsdrähten, welche am oberen Ende in eine Schlitzung mündet, und die konische Fräsung der Löcher für die erleichterte Einbringung der Verriegelungsbolzen. Vom Vorgängermodell wurden 220 Nägel eingesetzt, es kam in keinem Fall zu einem Materialversagen. Beantwortet sollte daher für die klinische Anwendung die Frage werden, ob die Änderung des Designs zu sog. Sollbruchstellen am Nagel bzw. im Nagel-Bolzen-System führt. Methode: Geprüft wurden zwei Gruppen á 5 Nägeln auf einer Zwick 010. Zur Untersuchung der maximalen Belastbarkeit (Peak load) von 8mm Nägeln am Übergang Zylinder- in U-Form (Schlitzung im proximalen Bereich) kam eine standartisierte Vier-Punkt-Biegung mit neu konzipierter Probenhalterung gemäß der Empfehlungen der ASTM (American Society for Testing and Materials) für die Prüfung intramedullärer Osteosynthesematerialien (Stützweite L=11,4cm; Last-Stütz-Abstand s=3,8cm; Lastweite c=3,8cm) zum Einsatz. Die Daten dieser Messungen im Schlitzbereich (5) wurden verglichen mit den Ergebnissen einer Belastungsprüfung im weiter distal gelegenen, zylindrischen Bereich des Nagels (5). Für die Prüfung des Nagel-Bolzensystems verwendeten wir auf Grund der zentralen Bohrung für Führungsdrähte eine modifizierte Vier-Punkt-Biegung mit ebenfalls neu konzipierter Probenhalterung. Die Peak load von 36mm Verriegelungsschrauben mit 4,5mm Gewindedurchmesser, eingeschraubt in eine Buchenhartholzhülse mit 19mm Stützweite, bei direkter Kraftübertragung mittels Standard-8mm-Nagels, wurde bestimmt. Ergebnisse: Die Grenze von elastischer zu plastischer Verformung der gepüften Nägel wurde im Schlitzbereich bei einer Last von F = 4.218 N, also einem um 17,68% geringeren Biegemoment erreicht (Rp0.1 bei 80,14 Nm;) als in zylindrischen Abschnitten (F = 5.049,5N). Im physiologischen Bereich kam es zu keinem Nagelbruch. Unter Verwendung des neuen Nagel-Bolzen-Systems kam es zum Bruch der geprüften Verriegelungsbolzen bei einer durchschnittlichen axialen Last von 2.510 N. Dies entspricht einem um 13,12% geringeren Biegemoment (Rp0.1 bei 8,16 Nm;) als unter Verwendung des Vorgängermodels. Zusammenfassung: Der zur operativen Versorgung von Tibiafrakturen neu konzipierte standardmäßig verwandte US-Nagel Depuy ACE Aim Dynamic ist ein außergewöhnlich sicheres System, was aus unseren Testergebnissen abgeleitet werden kann. Zwar zeigt dieser im Vergleich zu seinem Vorgängermodell Schwächen in der Belastbarkeit des Nagel-Bolzen-Systems. Dies erscheint aber unter Berücksichtigung der gängigen postoperativen Belastungssteigerung als unproblematisch.
© 2020-2025 Ivy Podcast Discovery LLC
